Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 1;32(3):389-392.
doi: 10.1097/EDE.0000000000001329.

Generalizability of Subgroup Effects

Affiliations

Generalizability of Subgroup Effects

Marissa J Seamans et al. Epidemiology. .

Abstract

Generalizability methods are increasingly used to make inferences about the effect of interventions in target populations using a study sample. Most existing methods to generalize effects from sample to population rely on the assumption that subgroup-specific effects generalize directly. However, researchers may be concerned that in fact subgroup-specific effects differ between sample and population. In this brief report, we explore the generalizability of subgroup effects. First, we derive the bias in the sample average treatment effect estimator as an estimate of the population average treatment effect when subgroup effects in the sample do not directly generalize. Next, we present a Monte Carlo simulation to explore bias due to unmeasured heterogeneity of subgroup effects across sample and population. Finally, we examine the potential for bias in an illustrative data example. Understanding the generalizability of subgroup effects may lead to increased use of these methods for making externally valid inferences of treatment effects using a study sample.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

Figures

Figure.
Figure.
Absolute value of bias and mean squared error (MSE) of the population average treatment effect estimates across simulation scenarios when baz = 0.15.

References

    1. Bengtson AM, Pence BW, Gaynes BN, Quinlivan EB, Heine AD, O’Donnell JK, Crane HM, Mathews WC, Moore RD, Westreich D, O’Cleirigh C, Christopoulos K, Mimiaga MJ, Mugavero MJ. Improving Depression Among HIV-Infected Adults: Transporting the Effect of a Depression Treatment Intervention to Routine Care. J Acquir Immune Defic Syndr 2016;73(4):482–488. - PMC - PubMed
    1. Lesko CR, Buchanan AL, Westreich D, Edwards JK, Hudgens MG, Cole SR. Generalizing Study Results: A Potential Outcomes Perspective. Epidemiology 2017;28(4):553–561. - PMC - PubMed
    1. Susukida R, Crum RM, Ebnesajjad C, Stuart EA, Mojtabai R. Generalizability of findings from randomized controlled trials: application to the National Institute of Drug Abuse Clinical Trials Network. Addiction 2017;112(7):1210–1219. - PMC - PubMed
    1. Kern HL, Stuart EA, Hill J, Green DP. Assessing methods for generalizing experimental impact estimates to target populations. J Res Educ Eff 2016;9(1):103–127. - PMC - PubMed
    1. Cole SR, Stuart EA. Generalizing evidence from randomized clinical trials to target populations: The ACTG 320 trial. Am J Epidemiol 2010;172(1):107–15. - PMC - PubMed

Publication types